# OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
> **ANDA208465** · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2026-03-31
## Drug
- **FDA Application Number:** ANDA208465
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
- **Generic name:** Hydrochlorothiazide
- **Active ingredients:** HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SCIEGEN PHARMS
- **First approval:** 2026-03-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208465)
---
*AI Analytics · CC0 1.0*